3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
103
Carcinoma, Renal Cell
70
Neoplasm Metastasis
48
Neoplasms
37
Neuroendocrine Tumors
33
Kidney Neoplasms
27
Recurrence
19
Tuberous Sclerosis
18
Carcinoma, Non-Small-Cell Lung
17
Prostatic Neoplasms
16
Triple Negative Breast Neoplasms
15
Lymphoma
15
Lymphoma, Mantle-Cell
14
Lymphoma, Large B-Cell, Diffuse
14
Head and Neck Neoplasms
14
Glioblastoma
14
Colorectal Neoplasms
13
Carcinoma, Hepatocellular
13
Stomach Neoplasms
12
Lung Neoplasms
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Hodgkin Disease
12
Brain Neoplasms
12
Sarcoma
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Pancreatic Neoplasms
11
Glioma
11
Waldenstrom Macroglobulinemia
10
Lymphoma, Follicular
10
Carcinoma, Neuroendocrine
10
Interventions
Ultrasonography
2
Tomography, X-Ray Computed
2
tremelimumab
1
lenvatinib
1
hepatitis C immune globulin, human
1
fluoromisonidazole
1
epigallocatechin gallate
1
durvalumab
1
babao dan
1
Vitamin B 6
1
Urination
1
Tomography
1
Tidal Volume
1
Rosuvastatin Calcium
1
Propranolol
1
Probiotics
1
Preoperative Exercise
1
Positron-Emission Tomography
1
Portasystemic Shunt, Transjugular Intrahepatic
1
Population Groups
1
Plasmapheresis
1
Oxaliplatin
1
Nadolol
1
Mebendazole
1
Introns
1
Immunoglobulin G
1
Glutathione
1
Gemcitabine
1
Furosemide
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Liver Cirrhosis
×
Everolimus
×
Clear all
NCT01423708
2012-07-18
EPOCAL
Azienda Ospedaliera di Padova
Phase 2
Unknown
117 enrolled